Condition: The Primary Objective of the NIS is to Evaluate the Severity of Newly Diagnosed Asthma Patients Based on GINA Severity Category (GINA 2006 Update).
Intervention:
Sponsor: AstraZeneca
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days